Pharmacy Clinical Pearl of the Day: Bladder Cancer

Bladder cancer most often begins in the cells that line the inside of the bladder.

Clinical Pearl of the Day: Bladder Cancer

Bladder cancer is a common type of the disease that begins in the cells of the bladder.

Insight:

  • The bladder is a hollow muscular organ in your lower abdomen that stores urine.
  • Bladder cancer most often begins in the cells (urothelial cells) that line the inside of the bladder.
  • Symptoms include blood in urine, frequent urination, painful urination, and back pain.
  • Types of bladder cancer include urothelial carcinoma, squamous cell carcinoma, and adenocarcinoma.
  • Risk factors include smoking, increasing age, being male, previous cancer treatment, and personal/family history of cancer.
  • Treatment includes surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Some of the drugs approved for bladder cancer include erdafitinib (Balversa), avelumab (Bavencio), cisplatin, doxorubicin , erdafitinib, Mitomycin (Jelmyto), pembrolizumab (Keytruda), nivolumab (Opdivo),enfortumab vedotin-ejfv (Padcev), and atezolizumab (Tecentriq).

Sources: